Separation systems for commercial biotechnology are becoming popular due to extensive research in biotechnology to introduce new products. These systems are witnessing rising demand from chemical, plastics, and agro-processing sectors due to growing adoption of highly advanced single-use bioprocessing systems. Commercial separation systems find applications in pharmaceuticals, agriculture, and food and cosmetics. In pharmaceuticals, these systems are used for mammalian cell cultures, enzymes, vaccines, proteins, human blood plasma fractionation, and hormones/insulin.
Constant Developments to Spur Pharmaceutical Applications
Pharmaceutical applications witnessed the highest demand for separation systems for commercial biotechnology. Many factors such as high demand for biotherapies, shortage of vaccines, and extensive research and development for drug innovation are expected to fuel demand in near future. Various research organizations, in cooporation with industrial partners, aim at developing projects and tab-on-a-chip technology for industrial use; particularly in pharmaceutical sector. Most research and development activities are focused on modern microfluidics devices, which can separate biomolecules. This factor is anticipated to drive segment expansion in the forthcoming years.
Constant advancements in upstream bioprocessing technology, which enables elimination of biohazardous by-products while simplification of methods, are also responsible for rising demand. For example, Thermo Fischer Scientific’s recently launched bioprocessing technology, Harvestainer Microcarrier Separation System. The new Harvestainer BioProcess Container (BPC) system is a single-use and self-contained solution for harvesting and separating cell cultures grown on microcarrier beads. The new system can enhance product yields better than conventional methods.
Market Insights
A research report by Grand View Research, Inc. predicts that the global separation systems for commercial biotechnology market would reach $39.47 billion by 2025. This growth can be attributed to contribution of prominent companies to boost commercial production and extensive R&D for novel technological and product development. In addition, growing use of advanced single-use bioprocessing systems in different sectors is likely to boost market expansion. Some of the prominent market players are Thermo Fisher Scientific; Shimadzu Corp.; Bio-Rad Laboratories, Inc.; Merck & Co., Inc.; and Hitachi Koki Co., Ltd.
In-Depth Research Report On Separation Systems for Commercial Biotechnology Market:
https://www.grandviewresearch.com/industry-analysis/separation-systems-for-commercial-biotechnology-market
I Like to add one more important thing here, The Separation Systems For Commercial Biotechnology Market was valued at US$ 10,660 Million in 2014 and is projected to grow at a CAGR of more than 6.5% in the given forecast period to cross US$ 21726 Million by 2025.
ReplyDelete